Martin Shkreli’s Former Company Ordered to Pay $40 Million in Settlement Over Price-Gouging Case

  • 📰 WSJ
  • ⏱ Reading Time:
  • 20 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 63%

Deutschland Nachrichten Nachrichten

Deutschland Neuesten Nachrichten,Deutschland Schlagzeilen

A drug company formerly run by Martin Shkreli was ordered to pay up to $40 million to settle allegations that it substantially raised prices of lifesaving medication

, the Federal Trade Commission said.

Vyera Pharmaceuticals LLC, which Mr. Shkreli ran as chief executive when it was called Turing Pharmaceuticals AG, purchased exclusive rights to antiparasitic drug Daraprim for $55 million in 2015 and raised the price of the drug to $750 per tablet from $17.50 a tablet, while preventing competitors from producing generic versions of it, according to court documents. The increase

 

Vielen Dank für Ihren Kommentar.Ihr Kommentar wird nach Prüfung veröffentlicht.

40 MiLliOn. Big fucking deal.

Wheels of justice are slow 😬

Pharma Bro 😎 Numero Uno. Does anyone remember when he wanted to buy the Wu Tang Clan rap album for his exclusive use? Whatever happened with that?

How much did he make. Again So corp merica acts out and steals , gobt says bad boi u owe us 2% back

Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen:

 /  🏆 98. in DE

Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen